欧洲首批COVID-19病例的临床与病毒学特征:病例系列
该病例系列报告了2020年1月24日起法国两家医院确诊的5例有中国旅行史的COVID-19患者,通过每日多次鼻咽、血液、尿液和粪便样本的半定量RT-PCR与病毒分离,描述了三种不同临床演变及病毒载量模式,其中1例80岁男性死亡。
要点
- 两例轻症女性发病24小时内鼻咽病毒载量高,粪便可检出病毒RNA。
- 两例年轻男性发病约10天后二次加重,但鼻咽病毒载量下降。
- 80岁男性快速多器官衰竭,上下呼吸道持续高载量并伴血浆病毒播散。
核心结论
- 5例SARS-CoV-2感染呈现三种不同临床与病毒学演变类型,提示疾病自然史的异质性。
研究设计与样本
- 病例系列,纳入法国Bichat-Claude Bernard大学医院与Pellegrin大学医院5例经鼻咽拭子半定量RT-PCR确诊的COVID-19患者。
主要发现
- 患者为3男2女、均为中国籍,2020年1月中旬从中国赴法。
- 两例轻症女性发病24小时内鼻咽病毒载量分别为5·2和7·4 log10 copies per 1000 cells,粪便检出病毒RNA。
- 两例年轻男性发病约10天二次加重,鼻咽病毒载量下降。
- 80岁男性快速进展为多器官衰竭,上下呼吸道持续高病毒载量,血浆检出病毒,于发病第14天(2020年2月14日)死亡。
- 其余患者至2020年2月19日均已康复出院。
临床怎么用
- 对COVID-19患者应结合病程多次多部位采样评估病毒载量,警惕发病约10天后的二次加重。
- 高龄患者出现持续高病毒载量及血浆病毒检出时需警惕重症与全身播散风险。
局限性
- 仅为5例病例系列,样本量小,结果不能外推至总体人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: On Dec 31, 2019, China reported a cluster of cases of pneumonia in people at Wuhan, Hubei Province. The responsible pathogen is a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report the relevant features of the first cases in Europe of confirmed infection, named coronavirus disease 2019 (COVID-19), with the first patient diagnosed with the disease on Jan 24, 2020. METHODS: In this case series, we followed five patients admitted to Bichat-Claude Bernard University Hospital (Paris, France) and Pellegrin University Hospital (Bordeaux, France) and diagnosed with COVID-19 by semi-quantitative RT-PCR on nasopharyngeal swabs. We assessed patterns of clinical disease and viral load from different samples (nasopharyngeal and blood, urine, and stool samples), which were obtained once daily for 3 days from hospital admission, and once every 2 or 3 days until patient discharge. All samples were refrigerated and shipped to laboratories in the National Reference Center for Respiratory Viruses (The Institut Pasteur, Paris, and Hospices Civils de Lyon, Lyon, France), where RNA extraction, real-time RT-PCR, and virus isolation and titration procedures were done. FINDINGS: The patients were three men (aged 31 years, 48 years, and 80 years) and two women (aged 30 years and 46 years), all of Chinese origin, who had travelled to France from China around mid-January, 2020. Three different clinical evolutions are described: (1) two paucisymptomatic women diagnosed within a day of exhibiting symptoms, with high nasopharyngeal titres of SARS-CoV-2 within the first 24 h of the illness onset (5·2 and 7·4 log10 copies per 1000 cells, respectively) and viral RNA detection in stools; (2) a two-step disease progression in two young men, with a secondary worsening around 10 days after disease onset despite a decreasing viral load in nasopharyngeal samples; and (3) an 80-year-old man with a rapid evolution towards multiple organ failure and a persistent high viral load in lower and upper respiratory tract with systemic virus dissemination and virus detection in plasma. The 80-year-old patient died on day 14 of illness (Feb 14, 2020); all other patients had recovered and been discharged by Feb 19, 2020. INTERPRETATION: We illustrated three different clinical and biological types of evolution in five patients infected with SARS-CoV-2 with detailed and comprehensive viral sampling strategy. We believe that these findings will contribute to a better understanding of the natural history of the disease and will contribute to advances in the implementation of more efficient infection control strategies. FUNDING: REACTing (Research & Action Emerging Infectious Diseases).
引用
- Lescure FX, Bouadma L, Nguyen D, et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020. PMID: 32224310. doi:10.1016/S1473-3099(20)30200-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。